Jane Street
STOK icon

Jane Street’s Stoke Therapeutics STOK Stock Holding History

Jane Street’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,400
Closed -$339K – 13072
2026
Q1 		$339K Sell
10,400
-4,700
-31% -$154K ﹤0.01% 8964
2025
Q4 		$479K Buy
+15,100
New +$454K ﹤0.01% 7788
2024
Q2 		– Sell
-12,200
Closed -$165K – 10161
2024
Q1 		$165K Buy
+12,200
New +$73.9K ﹤0.01% 8288

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jane Street's STOK Position: Q2 2026 in Review

Jane Street increased its Stoke Therapeutics (STOK) stake by 415% in Q2 2026, buying an estimated $8.58M and bringing the position to 331,701 shares worth $10.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2742.

Jane Street first reported a position in STOK in Q2 2020 and has held it in 17 quarters since. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Jane Street held 331,701 shares of Stoke Therapeutics worth $10.9M as of Q2 2026.
  • Jane Street bought 267,352 Stoke Therapeutics shares in Q2 2026, an estimated $8.58M.
  • Stoke Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #2742 holding.
  • Jane Street first reported a position in Stoke Therapeutics in Q2 2020 and has held it in 17 quarters since.
  • 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.